Mary C. Tanner

Mary Catherine Tanner is an investment banker, with more than 25 years of experience on Wall Street. She specializes in the areas of biotechnology, pharmaceuticals, and health care services.

Early life and education Mary Catherine Tanner was born to Donald N. Tanner and Marilyn S. Tanner. Her father was a civil engineer. Her mother was an educator working with learning-disabled children. Frank convinced Tanner to join his team at Lehman. Ten years later, on October 15, 1988, they were married.

As of March 18, 2009, Mary Tanner and Frederick Frank joined Peter J. Solomon, of PJ SOLOMON to form a new practice focusing on pharmaceuticals and life sciences. Tanner became a managing director at Peter J. Solomon, while Frank became a vice chairman.

As of January 15, 2013, Mary Tanner and Frederick Frank joined Burrill & Company. Tanner became the Senior Managing Director of Burrill Securities and of Burrill & Company.

As of 2014, Tanner and Frank founded EVOLUTION Life Science Partners (ELSP). Tanner is Senior Managing Director of EVOLUTION Life Science Partners (ELSP), and a co-founder and chair of Life Science Partners LLP. She also represented Amgen when it acquired Immunex for $16 billion. Tanner has served on the Dean's Council for the Yale School of Medicine and on the advisory board for the Yale School of Management (SOM). Tanner and Frank have made multiple gifts to Yale, and the creation of the Frank and Tanner Professor of Management at the Yale School of Management, to which Olav Sorenson was appointed on April 9, 2012.

Awards and honors 2012, Oracle award, Springboard Enterprises, for professional accomplishment and mentoring of women entrepreneurs.